title: Modified lipoproteins as biomarkers of cardiovascular risk in diabetes mellitus.
abstract: Prevention of high incidence of cardiovascular disease in diabetes is one of the challenges of endocrinology. Validation of new biomarkers that may contribute to a better assessment of cardiovascular risk and help implement treatment strategies is one of the promising approaches in research on prevention and reduction of cardiovascular risk. Modification of low density lipoprotein (LDL) is a key element in development of atherosclerotic lesions. Several pathophysiological characteristics of diabetes are crucial for the LDL of these patients to have higher modification rates as compared to the healthy population. Diabetic dyslipidemia, hyperglycemia, and oxidative stress synergistically promote the occurrence of lipoperoxidation, glycosylation and glycoxidation processes, which will generate modified lipoproteins that stimulate development of atherosclerosis. This article reviews the role of different types of modified LDL in development of atherosclerosis in diabetes, as well as the possibility of using its quantification in cardiovascular risk prediction.
authors.affiliation: Grupo de Bioquímica Cardiovascular, Instituto de Investigación Biomédica Sant Pau, Barcelona, España. Electronic address: jsanchezq@santpau.cat.
authors.forename: José Luis
authors.initials: JL
authors.lastname: Sánchez-Quesada
authors.forename: Antonio
authors.initials: A
authors.lastname: Pérez
mesh_terms: D050197:Atherosclerosis / Q000097:blood / Q000453:epidemiology; D015415:Biomarkers / Q000097:blood / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000097:blood* / Q000453:epidemiology*; D048909:Diabetes Complications / Q000097:blood* / Q000453:epidemiology*; D006801:Humans; D008077:Lipoproteins, LDL / Q000097:blood* / Q000378:metabolism; D018570:Risk Assessment
chemical_list: D015415:Biomarkers; D008077:Lipoproteins, LDL
keywords: Arteriosclerosis; Atherosclerosis; Biomarcadores; Biomarkers; Cardiovascular risk; Diabetes mellitus; Lipoproteínas modificadas; Modified lipoproteins; Riesgo cardiovascular